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Background:  Over  6 million  people  die  annually  in  the  world  because  of  cancer.  Several  groups  are  focused
on studying  cancer  chemoprevention  approaches.  Resveratrol,  a polyphenol,  at high dosages,  has  been
reported  as  antitumor  and  chemopreventive.  However,  it has  a dose-dependent  effect  on cell  death,  even
on some  cancer  cells.
Objectives: Our  aim  was  to  investigate  this  dose-dependent  effect  on human  bladder  carcinoma  ECV304
cells during  oxidative  stress  condition.
Methods:  For  this  purpose,  ECV304  cells incubated  with  different  Resveratrol  concentrations  were  ana-
lyzed as for  their  metabolic  rate,  membrane  permeability,  DNA  fragmentation,  anti/proapoptotic  protein
levels and  phosphatidylserine  exposure  after  oxidative  stress.
Results:  Resveratrol  induced  cell  death  at high  concentrations  (>20  M), but  not  at low  ones  (0.1–20  M).
Pretreatment  with  2.5  M protected  the  cells  from  oxidative  damage,  whereas  50 M  intensiﬁed  the
cell  death  and  signiﬁcantly  increased  Bad/Bcl-2  ratio (proapoptotic/antiapoptotic  proteins).  Resveratrol
was able  to  modulate  NO and  PGE2 secretion  and  performed  an  anti-adhesion  activity  of  neutrophils  on
PMA-activated  ECV304  cells.
Conclusions:  Resveratrol  at  high  doses  induces  cell  death  of  ECV304  cells  whereas  low  doses  induce  protec-
tion.  Modulation  of  Bcl-2  protein  induced  by  Resveratrol  could  be  mediating  this  effect.  This  information
about  the  role  of  Resveratrol  on cancer  alerts  us about  its  dose-dependent  effects  and  could  lead  the
design  of future  chemoprevention  strategies.
Published by Elsevier Ireland Ltd.
1. Introduction
Cancer is the largest single cause of death both in men  and
women, claiming over 6 million lives each year worldwide. Chemo-
prevention, the prevention of cancer by ingestion of chemical
agents that reduces the risk of carcinogenesis [1],  is one of the most
direct ways to reduce morbidity and mortality. Public health pol-
icy initiatives have, thus, been focused on the “chemoprevention”
of cancer, wherein occurring naturally or when synthetic chemi-
cal agents are used for the inhibition, delay or, even, reversal of
carcinogenesis [2].
Resveratrol, a polyphenol derived from red grapes, berries, and
peanuts, has been shown to modulate death of a wide variety
of cells and also has been linked with suppression of inﬂamma-
tion, arthritis, cardiovascular diseases, and delaying of aging [3].
∗ Corresponding author at: Av do Café, S/N, Bloco M,  Sala 52, Ribeirao Preto, Sao
Paulo, ZIP 14040-903, Brazil. Tel.: +55 16 3602 4220/4208; fax: +55 16 3602 4725.
E-mail address: torqueti@fcfrp.usp.br (M.R. Torqueti Toloi).
Resveratrol is an excellent scavenger of hydroxyl, superoxide, and
other radicals [4].  It also protects against lipid peroxidation in cell
membranes and DNA damage caused by reactive oxygen species
generation [4].  Resveratrol was further demonstrated to be an anti-
tumor and chemopreventive agent; and found to affect cellular
proliferation through its action on tumor initiation, promotion, and
progression [5,6]. These properties have been explained mainly by
its activities in cell cycle control and apoptosis induction [7,8].
A preliminary study has investigated the chemopreventive
potential of Resveratrol against bladder cancer (T24 cells line)
and its mechanism of action [9].  It has been demonstrated that
treatment of bladder cancer cells with high doses of Resvera-
trol (>25 M)  resulted in a signiﬁcant decrease in cell viability by
inducing apoptosis and cell cycle arrest. In fact, Resveratrol has
been reported to facilitate apoptotic cell death and it behaves as
a chemopreventive alternative when administered in higher doses
[10]. On the other hand, at very low concentrations (<20 M),  this
same Resveratrol is able to inhibit apoptotic cell death, providing,
thereby, protection against various diseases, including myocar-
dial ischemic reperfusion injury, atherosclerosis, and ventricular
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arrhythmias [3].  Thus, Resveratrol plays a dose-dependent bipha-
sic effect on death cell, even on cancer cells [11]. The present paper
was designed to study the dose-dependent effect of Resveratrol
on cell viability and its antioxidant role on ECV304 cells, a deriva-
tion from the human bladder carcinoma T24 cell line. Moreover,
the Resveratrol activity as an inﬂammatory modulator molecule
was also evaluated on those cells through nitric oxide (NO) and
prostaglandin E2 (PGE2) analysis.
2. Methods
2.1. Preparation of Resveratrol solutions
Resveratrol was purchased from Sigma–Aldrich (St. Louis, USA;
catalog number: R5010), dissolved in DMSO (dimethyl sulfoxide;
Sigma–Aldrich), and stored at −20 ◦C. For all experiments, the ﬁnal
concentrations of Resveratrol were prepared by diluting the stock
in RPMI-1640 medium and then, in sterilized ﬁlter. The ﬁnal con-
centration of DMSO in cultured medium was less than 0.5%, which
caused no measurable effect on cell growth.
2.2. Treatment of cell culture
In all experiments were used bladder carcinoma cell line
ECV304, a derivation from the human bladder carcinoma T24 cell
line (American Type Culture Collection, Manassas, USA). This line
was cultivated in RPMI 1640 medium supplemented with 10% heat-
inactivated fetal bovine serum (FBS) (Hyclone, Logan, USA), 2 mM
l-glutamine, 0.075% sodium bicarbonate, 100 U/ml penicillin and
10 mg/ml  streptomycin (Invitrogen, Life Technologies, Carlsbad,
USA) at 37 ◦C in 5% CO2. Conﬂuent ECV304 cells were previously
incubated with different Resveratrol concentrations (0.1–100 M).
After 30 min  at 37 ◦C, oxidative stress was induced by adding 50 M
H2O2 (hydrogen peroxide) which was maintained for 6 h [12]. In
this protocol, total time of Resveratrol exposition was  6 h 30 min.
At the end of the incubation period, different parameters were
analyzed as described below. When necessary, normal ﬁbroblast
cells (LLCMK2, ATCC CCL-7.1) were incubated with Resveratrol.
This cell line was cultivated in the same conditions that ECV304
cells.
2.3. MTT  assay
The cell metabolism of ECV304 cells was  measured by
MTT  (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) assay as previously described [13]. Brieﬂy, conﬂuent ECV304
cells cultivated into 96-well culture plates were treated with vari-
ous concentrations of Resveratrol for 6 h 30 min. Triton (10%) was
used as death control. After incubation, the medium was  removed,
the cells were washed with phosphate-buffered saline (PBS) and,
subsequently, incubated with 0.5 mg/ml  MTT  (Sigma–Aldrich) for
additional 4 h. Later, 0.2 ml  of lysis buffer (isopropyl alcohol con-
taining 10% Triton X-100 and 0.1 N HCl) was added to dissolve the
formazan crystals, and then, the absorbance was  measured in a
spectrophotometer at 570 nm.
2.4. Flow cytometric analysis
Cells (105) cultivated in 12-well culture plates were appropri-
ated treated with RSV and stimulated or not with H2O2. Apoptosis
and necrosis signals were investigated in these cells by propid-
ium iodide (PI; Sigma–Aldrich) staining. Membrane permeability
in fresh ECV304 cells was evaluated immediately after PI addition
(5 g/ml). DNA degradation was detected in ECV304 cells gently
resuspended in 0.5 ml  of hypotonic propidium iodide solution (PI,
50 g/ml in 0.1% sodium citrate plus 0.1% Triton X-100). The tubes
were kept at 4 ◦C for 16 h in the dark.
In order to investigate the phosphatidylserine exposition on
ECV304 cell surface, at the end of incubation these cells with
RSV and/or H2O2 they were washed at least twice in sterile PBS
and, then, incubated in a 100-l ﬁnal volume in HEPES buffer
(10 mM HEPES, 140 mM NaCl2, 5 mM CaCl2, pH 7.4) containing
Alexa 488-conjugated AnnexinV (2:100) (Invitrogen, Life Technolo-
gies, Eugene, USA) for 15 min  at 4 ◦C. After incubation it was added
a buffer and propidium iodide (PI). Samples were acquired imme-
diately by ﬂow cytometry.
Nitric oxide intracellularly generated was measured by using
4,5-diaminoﬂuorescein diacetate (DAF-2 DA; Sigma–Aldrich),
which is membrane permeable [14]. ECV304 cells (106) were
incubated with different Resveratrol concentrations (0–50 M)  for
60 min  in the presence of DAF-2DA (2 M).  Cells were washed twice
in PBS and immediately acquired by ﬂow cytometry.
In all assays the samples were acquired by ﬂow cytometry FACS
Canto (Becton Dickinson, Mountain View, USA) and analyzed in the
DIVA software (Becton Dickinson).
2.5. DNA fragmentation
Cells were treated as previously described, centrifuged, resus-
pended in 500 l of lysis buffer (Tris 10 mM,  EDTA 1 mM,  0.2%
Triton X-100, pH 7.4), and incubated overnight at 4 ◦C. The sam-
ples were centrifuged and the supernatants were treated with
100 g/ml RNAse (Invitrogen) for 1 h at 37 ◦C followed by 0.1 mg/ml
proteinase K (Invitrogen) for 1 h at 57 ◦C (134.6 ◦F). Nucleic acids
were extracted with phenol:chloroform:isoamyl alcohol (25:24:1)
(BioAgency, São Paulo, BR) and precipitated with ethanol (P.A) [15].
After ethanol precipitation, nucleic acid was resuspended in TE
buffer (10 mM Tris–HCl pH 7.4, 10 mM  EDTA). Finally, the resus-
pended DNA was subjected to electrophoresis in a 2.0% agarose gel
at a constant voltage of 40 V for 2 h [16].
2.6. Immunoblotting
After treatment with Resveratrol, cultures were washed twice
with PBS and lyzed in boiling sample buffer (62.5 M Tris, pH 6.8,
2% SDS (w/v), 5% glycerol (v/v), 30 M phenol red and 0.9% -
mercaptoethanol). Samples were incubated for 5 min  at 100 ◦C,
centrifuged, and loaded in 15% polyacrylamide gels. Nitrocellu-
lose electroblotted membranes (Amersham Biosciences, Uppsala,
Sweden), saturated with 5% non-fat dry milk, were sequentially
incubated with primary and secondary antibodies, washed in TBS-T
and revealed using a super-signal luminol substrate (Pierce). Den-
sitometry analyses were done using ImageJ software. Antibodies
for Bcl-2 (1:1000; catalog number 551109), Bad (1:500; catalog
number 610391) and caspase-3 (1:1000; catalog number 557035)
were obtained from BD Pharmingen. Antibodies for caspase-9
(1:250; catalog number C4356) and tubulin (1:1000; catalog num-
ber T3320) were obtained from Sigma. Secondary antibodies were
obtained from Jackson ImmunoResearch Inc.
2.7. Enzyme-linked immunosorbent assay (ELISA)
The levels of PGE2 were determined in the supernatant of cul-
tures previously treated with Resveratrol (0–50 M)  for 24 h at
37 ◦C. A competitive immunoassay was performed following man-
ufacturer’s instructions (PGE2 assay kit R&D Systems, Minneapolis,
USA). The colorimetric reaction was measured in spectrophotome-
ter at 450 nm.  The detection limit of these assays was 10 pg/ml.
Lipopolysaccharide (LPS, 1 g/ml) was used as positive control to
PGE2 production.
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Fig. 1. Resveratrol presents a dose-dependent effect on ECV304 cell viability.
ECV304 cells were incubated with Resveratrol (0.1–100 M)  during 6 h 30 min. In
these conditions were analyzed the (A) cell viability by MTT  assay and (C) the per-
meability membrane (PI staining), as well as the DNA content by ﬂow cytometry.
(B)  Bladder cancer cells (ECV304) and ﬁbroblast cells (LLCMK2) were incubated with
2.5 M Resveratrol during different times and analyzed by MTT  assay. In (A) and (B)
data  are reported as mean from three independent experiments ± S.E.M. *p < 0.05
compared to viable cells (V). In (C) results shown are representative of three inde-
pendent experiments done in triplicate. V, cells incubated with medium alone; M,
cells incubated with 10% Triton-X; P4, not permeable plasmatic membrane; P5,
permeable plasmatic membrane; P1, fragmented DNA; P2, not fragmented DNA.
2.8. Adhesion assay
Adhesion assays were performed in 24-well culture plate con-
taining inside sterile cover slips. Human neutrophils were isolated
as described [17] and added to monolayers of conﬂuent ECV304
cells previously stimulated with PMA  (Phorbol Myristate Acetate;
10 ng/ml, Sigma–Aldrich) for 5 h in the presence of 5 M Resver-
atrol. At the end of incubation time, the adherent neutrophils
were stained using HEMA3 (Biochemical Sciences, Inc., Swedes-
boro, USA), counted and expressed as number of neutrophils/ﬁeld.
2.9. Statistical analysis
Statistical comparison was carried out with three or more
groups using one-way analysis of variance (ANOVA) and Tukey’s
test. The data represent mean ± S.E.M. and values of p < 0.05 were
statistically signiﬁcant.
3. Results
3.1. Effect of Resveratrol on ECV304 cell viability
To evaluate if Resveratrol has any effect on ECV304 cell via-
bility, these cells were treated with different concentrations of
Resveratrol (0.1–100 M)  for 6 h 30 min  at 37 ◦C. First, cell viabil-
ity was measured by MTT  assay and showed as growth inhibition
(%) (Fig. 1A). Cells incubated with medium alone presented 100% of
viability. Low concentrations of Resveratrol (0.1–25 M)  were not
Fig. 2. Resveratrol at high dose increases the oxidative stress cell damage on ECV304
cells. The cells were previously incubated with Resveratrol (50 M) for 30 min. H2O2
(50 M)  was added and maintained for 6 h in the culture. Permeability membrane
(PI  staining) and DNA content were analyzed by ﬂow cytometry. The results shown
are representative of three independent experiments done in triplicate. P4, not per-
meable plasmatic membrane; P5, permeable plasmatic membrane; P1, fragmented
DNA; P2, not fragmented DNA.
able to inhibit cell growth of ECV304. These results were main-
tained even when 2.5 M Resveratrol was  tested in additional
times (Fig. 1B). In addition, the same Resveratrol concentration
was  not able to inhibit the growth cellular of ﬁbroblast cells
(Fig. 1B). However, ECV304 cells incubated with higher Resveratrol
concentrations (50–100 M)  have shown statistically signiﬁcant
decrease in their cell growth (Fig. 1A). Using a second experimen-
tal approach, the cells were incubated with low (2.5 M)  and high
(50 M)  doses of Resveratrol during 6 h 30 min. By ﬂow cytometry,
the cell permeability (PI staining) and DNA content were analyzed
(Fig. 1C). The treatment of cells with Resveratrol at low doses did
not induce statistically signiﬁcant changes when compared to the
cells that received only medium. On the other hand, a high dose of
Resveratrol succeeded in increasing the cell permeability (14.3%)
and the loss of DNA content (4.6%) (Fig. 1B).
3.2. Dual effect of Resveratrol, anti and pro-oxidant, on bladder
carcinoma cell line ECV304
Oxidative stress induced by 50 M H2O2 was used to test the
anti and pro-oxidative activities of Resveratrol on bladder car-
cinoma cell line ECV304. For this purpose, different parameters,
such as cell permeability, DNA content and phosphatidylserine
exposure, were assayed. ECV304 cells were pretreated with 50 M
Resveratrol for 30 min  and then 50 M H2O2 was added to the
cell culture. After 6 h of incubation, the signals of cellular damage
induced by the oxidative stress were analyzed by ﬂow cytometry
assays (Fig. 2). Cells incubated with medium alone showed a basal
level of cell permeability (7.5%), which was increased to 40.7% when
H2O2 was added to the culture. The percentage of cells positive to PI
staining (necrotic cells) was  highlighted in the presence of Resver-
atrol at high dose (73%) (Fig. 2). In the same way, the DNA damage
induced by oxidative stress (10.9%) has increased (81%) by 50 M
of Resveratrol (Fig. 2). Untreated cells presented 2.1% of DNA lost
(apoptotic signal).
In parallel, ECV304 cells maintained in oxidative stress con-
ditions were pretreated with 2.5 M Resveratrol for 30 min as
described above. ECV304 cells incubated with medium alone
showed basal levels of cell permeability (9.1%) (Fig. 3A) and loss
of DNA content (5.6%) (Fig. 3B). Incubation with 2.5 M Resvera-
trol alone did not induce statistically signiﬁcant cell modiﬁcations.
On the other hand, when 50 M of H2O2 was  added to the cell cul-
ture, around 47% of the cells lost plasma membrane integrity and
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Fig. 3. Resveratrol at low dose decreases the oxidative stress cell damage on ECV304
cells. Cells were previously treated with 2.5 M Resveratrol for 30 min  and then
50  M H2O2 was  added to the cell culture. After 6 h of incubation the cells were
analyzed by ﬂow cytometry: (A) permeability membrane by PI staining; (B) DNA
content; and, (C) double-stained using AnnexinV and PI. The results shown are rep-
resentative of three independent experiments done in triplicate. P4, not permeable
plasmatic membrane; P5, permeable plasmatic membrane; P1, fragmented DNA; P2,
not fragmented DNA; Q1, necrotic; Q2, late apoptotic; Q3, living; Q4, early apoptotic
cells.
around 35% of them presented loss of DNA content (Fig. 3A and B).
This way, the presence of RSV during the oxidative stress induced
by H2O2 signiﬁcantly reduced the cell damage signals, by 22.1% of
cell permeability and approximately 11.1% lost DNA content.
The phosphatidylserine was evaluated in association with the
cell permeability for a better evaluation and characterization of
cell death (Fig. 3C). We  considered PI−AnnexinV− cells as viable
ones (Q3 region), PI+AnnexinV− cells as necrotic ones (Q1 region),
PI−AnnexinV+ as apoptotic ones (Q4 region) and PI+AnnexinV+ as
cells in later apoptosis process (Q2 region). Thus, we could observe
that ECV304 cells incubated with medium or Resveratrol alone pre-
sented similar percentage of apoptotic, necrotic and late apoptotic
cells, 3%, 7% and 2% respectively. Oxidative stress enhanced per-
centages of necrotic cells (15%) ones and later apoptotic cells (7%).
The pre-incubation of the cells with RSV reduced the damaged cells
to similar levels as those incubated with medium alone (Fig. 3C).
Finally, we regarded the presence of DNA degradation in the
cells pretreated with RSV and incubated with H2O2 (Fig. 4). DNA
samples from ECV304 cells cultivated in different conditions were
assayed in agarose gel by GelRed staining. The treatment of cells
with H2O2 induced a strong DNA degradation when compared to
samples from cells incubated with medium or RSV alone. However,
the extension of DNA degradation induced by H2O2 was reduced
when the cells were previously treated with RSV for 30 min.
3.3. Resveratrol treatment modulates levels of Bcl-2 and Bad
proteins
Studies have suggested that Resveratrol alters cell viability by
modulating Bcl-2 protein families, which are involved in promoting
the apoptosis process [18,19]. We  examined the effect of Resvera-
trol treatment on two members of Bcl-2 protein family (Bcl-2 and
Bad) in ECV304 cells. As shown by immunoblot analysis and its den-
sitometric quantiﬁcation (Fig. 5), Resveratrol treatment of ECV304
cells at high doses (RSV 50) resulted in a decrease in antiapoptotic
Bcl-2 and a concomitant increase in proapoptotic Bad proteins. This
Fig. 4. Resveratrol protects ECV304 cells against DNA degradation induced by oxida-
tive  stress. Cells were previously treated with 2.5 M Resveratrol for 30 min  and
then  50 M H2O2 was added to cell culture. After 6 h of incubation the cells were
processed as described in Section 2. DNA fragmentation was analyzed by elec-
trophoresis in agarose gel. The result shown is representative of three independent
experiments done in triplicate.
Fig. 5. Effect of Resveratrol on the levels of proteins involved in cell death control.
ECV304 cells were incubated with Resveratrol (2.5 or 50 M) during 6 h 30 min
and analyzed by immunoblotting for speciﬁc proteins. Equal loading was conﬁrmed
by  stripping the blot and reprobing it for tubulin (endogenous control). (A) Bands
are  from a representative experiment repeated three times with similar results.
(B)  Bad/Bcl-2 ratio from relative density normalized to tubulin. Data are reported
as  mean ± S.E.M. from three independent experiments done in triplicate. *p < 0.05
compared to medium alone.
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effect caused a signiﬁcant increase in the Bad/Bcl-2 ratio (∼51%)
that favors apoptosis. On the other hand, Resveratrol treatment at
low doses increased both proteins, Bcl-2 and Bad. In this condition,
there was a smaller increase of Bad/Bcl-2 ratio (∼29%) compared to
that at high doses. The levels of caspase-3 during Resveratrol treat-
ment were also assessed. In any condition, Resveratrol treatment
was able to alter the caspase-3 levels (Fig. 5).
3.4. NO and PGE2 generation in Resveratrol-treated cells
We  tested the effects of the Resveratrol on NO and PGE2
synthesis (Fig. 6). We  administered to ECV304 cells increasing con-
centrations of Resveratrol (0–50 M)  and the NO production was
measured using the NO sensitive ﬂuorescent dye DAF-2 DA. In order
to determine whether NO is produced or not produced as a result
of treating ECV304 cells with Resveratrol, the ﬂuorescence signal
on cells loaded with DAF-2 DA was measured before and after the
addition of Resveratrol. After 60 min  of treatment we could observe
that all Resveratrol concentrations tested were able to induce NO
release compared with the control (cells incubated with medium
alone) (Fig. 6A). In contrast, the presence of PGE2 was not detected
by immunoenzymatic assay on the supernatant from ECV304 incu-
bated with different Resveratrol concentrations (Fig. 6B). Whereas,
our positive control, LPS, has succeeded in stimulating the ECV304
cells to secrete more than 150 pg/ml of PGE2.
3.5. Resveratrol effect on neutrophil adhesion on ECV304 cells
Neutrophil adhesion on ECV304 cells, an important event during
inﬂammatory process, was assayed in the presence of Resvera-
trol. For this purpose, human puriﬁed neutrophils were added
on ECV304 cells monolayer previously incubated with PMA  in
the presence of Resveratrol (Fig. 6C). Adherent neutrophils were
counted and expressed as neutrophils/ﬁeld. ECV304 cells not stim-
ulated with PMA  and cultivated with medium or Resveratrol alone
presented a basal number of adherent neutrophils (Fig. 6C). This
number was increased when the ECV304 cells were stimulated with
PMA  in the absence of Resveratrol. On the other hand, the presence
of Resveratrol has inhibited 50% of the neutrophil adhesion induced
by PMA.
4. Discussion
Resveratrol is currently being evaluated as a potential cancer
chemoprevention agent against several kinds of tumors such as
leukemia, prostate, breast, and colon cancers [19–21].  Previous
work has demonstrated that a high dose of Resveratrol is able to
induce apoptosis and cell cycle arrest of human T24 bladder [9].
However, there are a lot of reports describing the dual effects of
Resveratrol on cell viability on dose-dependent manner, includ-
ing normal and cancer cells [3,10,19,20,22].  Thus, the aim of the
present study was to evaluate the effects of Resveratrol, at low and
high doses, on cell viability of bladder carcinoma cell line ECV304
during an oxidative stress condition.
Brieﬂy, we have observed a biphasic effect of Resveratrol on cell
viability of ECV304 cells, since at high concentrations (>20 M)  it
has induced death cell, whereas at low concentrations (0.1–20 M)
it has not and also protected them from oxidative stress. In addition,
Resveratrol at low doses modulated the secretion of NO and PGE2
by ECV304 cells and played an anti-adhesion activity of neutrophils
on PMA-activated cells.
Cell viability of bladder carcinoma cell line ECV304 was evalu-
ated by MTT  assay and ﬂow cytometry in the presence of different
Resveratrol concentrations (0.1–100 M).  ECV304 cells present
some advantages for this study: (i) they are a derivation from the
Fig. 6. Resveratrol modulates NO and PGE2 synthesis and plays anti-inﬂammatory
role. (A) ECV304 cells were pretreated with 2 M of DAF-2 A and subsequently
Resveratrol (0–50 M)  was added in the culture. After 1 h, intracellular NO produc-
tion was analyzed by ﬂow cytometry. (B) Resveratrol (0–50 M)  was  maintained for
24  h in the culture. PGE2 was quantiﬁed by immunoenzymatic assay. Medium alone
(C)  and LPS (1 g/ml) were used as negative and positive controls, respectively. (C)
Cells were stimulated with 10 ng/ml of PMA  (Phorbol Myristate Acetate) for 5 h in
the  presence or absence of 5 M Resveratrol. It was allowed neutrophil adhesion
for  45 minutes. The adherent neutrophils were counted and expressed as number
of  neutrophils/ﬁeld. All data are reported as mean ± S.E.M. from three independent
experiments done in triplicate. *p < 0.05 compared to RSV 0 M in (A), to medium
alone or C in (B) and to PMA  in (C).
human bladder carcinoma T24 cell line, (ii) produce some inﬂam-
matory mediators, (iii) appropriated for metabolism studies and
(iv) are easily maintained in vitro culture [23]. Our data show that, at
low concentrations (0.1–25 M),  Resveratrol decreases neither cell
viability nor DNA content, and does not induce a signiﬁcantly cell
permeability. On the other hand, at highest concentrations tested
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(>25 M),  it was able to decrease the cell growth such as the DNA
content and to increase the percentage of cells that present perme-
ability, i.e.,  signals of death cell. This biphasic effect of Resveratrol
already has been demonstrated to other kind of cells, including nor-
mal  and cancer cells [11,24]. In prostate cancer cells, the effect of
Resveratrol on DNA synthesis varied dramatically, depending on
the concentration and the duration of treatment. Using an extended
treatment it was observed a dual effect of Resveratrol on DNA syn-
thesis. At 5–10 M it caused a 2- to 3-fold increase in DNA synthesis,
and at >15 M,  it inhibited DNA synthesis [11]. A second study
reported that low doses (0.1–1.0 g/ml) of Resveratrol enhance cell
proliferation, higher doses (10.0–100.0 g/ml) induce apoptosis
and decrease mitotic activity in colon cancer cells and endothe-
lial cells [24]. Together, our results clearly corroborate with other
previous ones about the importance of concentration to diverse
activities of Resveratrol. Moreover, we have added new informa-
tion about the effects of Resveratrol on bladder cancer cells since
this polyphenol can induce or not these cells to die, depending on
the dose used in a particular situation.
In an effort to try to understand better the effects of low
concentrations of Resveratrol on bladder carcinoma cell line
ECV304 we have investigated its antioxidant role on these cells.
Resveratrol at low concentration (2.5 M)  was suited to play a
protective effect on ECV304 cells from damage induced by oxida-
tive stress. These conclusions were constructed from PI staining,
DNA content, phophatidylserine exposure and DNA fragmentation
assays. Interestingly, Resveratrol has induced release of nitric
oxide from ECV304 cells. Reactive oxygen species (ROS) have
been regarded as toxic products of metabolism because of their
damaging effects on structural and functional molecules that,
eventually, result in apoptosis and uncontrolled proliferation [25].
Although, Resveratrol has induced secretion of ROS from ECV304,
it protected them from exogenous oxidative stress such as other
natural antioxidants from vegetable foods that can counteract the
effects of ROS [22]. Our group has demonstrated previously that
soy extracts are also apt to activate NO synthesis in ECV304 cells
and to protect them against cell damage [26]. According to the
same authors, this antioxidant activity played by Resveratrol can
be traced back to its cancer chemoprevention ones [5,27],  since
free-radical-mediated oxidative damage of DNA would be involved
with the development of cancer cells [28]. On the other hand, more
and more experimental evidence suggests that natural antiox-
idants play a chemopreventive role in an independent-manner
on their ability to scavenge reactive oxygen species [2].  In face of
these bases, we think that more investigations are necessary to
elucidate the molecular events contributing to the antioxidative
effect of Resveratrol on cancer cells.
The molecular mechanisms underlying the dual effect of Resver-
atrol on cell viability are not well understood. Some studies have
shown that Resveratrol is able to modulate proteins involved with
the control of apoptosis in mammalian cells [18,19].  Bcl-2 protein
families are important regulators of death cell. Our results demon-
strate that the treatment with Resveratrol alters the expression
levels of Bcl-2 protein families on a dose-dependent manner. In
summary, at low or high doses, Resveratrol increases the Bad lev-
els, a proapoptotic protein. On the other hand, the levels of Bcl-2,
an antiapoptotic protein, are signiﬁcantly reduced when the cells
are treated with high doses of Resveratrol. The densitometric quan-
tiﬁcation analysis indicates that Resveratrol down-modulates the
Bad/Bcl-2 ratio by 29% at low doses and 51% at high doses. Although
Resveratrol, at low or high doses, induces the increase of proapop-
totic protein levels (Bad), it signiﬁcantly decreases the expression
of Bcl-2, an antiapoptotic molecule, when assayed at high doses. It
is believed that, the different susceptibility to cell death shown by
ECV204 from natural or oxidative stress is mediated by the modula-
tion of Bcl-2 expression induced by different doses of Resveratrol. In
addition, the death of ECV304 cells induced by high doses of Resver-
atrol is a caspase-independent process since caspase-3 levels were
not altered.
Finally, we have evaluated some aspects related to the regula-
tion of inﬂammation process by Resveratrol on ECV304 cells, since
chronic inﬂammation can lead to cancer and other numerous dis-
eases (diabetes, and cardiovascular, pulmonary, and neurological
diseases) [3].  Resveratrol did not stimulate PGE2 secretion, but
it was efﬁcient to inhibit the neutrophil adhesion. These results
appoint Resveratrol as an important modulator of pivotal points
during an inﬂammatory response, i.e.,  secretion of proinﬂammatory
molecules and inﬂammatory cell adhesion. Moreover, we rein-
force the idea that Resveratrol is a nonsteroidal anti-inﬂammatory
molecule and possess potential application in the treatment and
prevention of various inﬂammatory diseases.
The consumption of polyphenols used as hormone therapy,
mainly by postmenopausal women, has been widely accepted.
Resveratrol is abundant in red wine with concentrations rang-
ing from 10 to 20 M [6,7]. The works show that Resveratrol is
rapidly absorbed and metabolized. After consumption of wine, the
concentration of free form of Resveratrol and its metabolites in
human plasma is great inter-individual variable. The maximum
plasma concentration was observed 1 h after oral intake and a sec-
ond peak was  present after 6 h [29]. These data, in association with
our results, suggest that moderate consumption of red wine (2–3
glasses/day) can proportionate a low dose of serum Resveratrol by
enough time to protect the cells from oxidative damage but cannot
kill cancer cells.
Further studies are required to better characterize its dual
effects on cell death, mainly on cancer cells. Our ﬁndings clearly
demonstrate that, at low concentrations, Resveratrol does not kill
the bladder carcinoma cell line ECV304. In contrast, it protects them
from oxidative stress damage and stimulates an anti-inﬂammatory
environment. On the other hand, high doses of Resveratrol induce
cell death and increases cell damage from oxidative stress. Our
data suggest that these effects are mediated by Bcl-2 antiapoptotic
protein, which is down-modulated by high doses of Resveratrol.
Several chronic medical conditions can develop after menopause:
cardiovascular disease, osteoporosis, weight gain, urinary inconti-
nence and some types of cancers, such as bladder cancer. Studies
have been demonstrated that postmenopausal women present
a statistically signiﬁcant risk of bladder cancer compared with
premenopausal women [30]. During our text, we described that
Resveratrol is used as alternative hormone replacement therapy for
these women. More recently its importance as antitumoral agent
was  reported. We  believe that our results provide useful informa-
tion for antioxidant and chemoprevention drug design. In addition,
they can assist postmenopausal women to better choice their hor-
mone therapy jointly their doctors.
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